We are the data and application backbone for Life Sciences market access and commercialization. When a drug is commercialized, Life Sciences companies need to distribute product, support patients, and secure government and commercial contracts. IntegriChain uniquely delivers all the data, applications, and business process infrastructure that support those functions. More than 250 Life Sciences companies rely on our ICyte SaaS platform to power strategic decision-making for market access and commercialization. ICyte closes the data and systems chasm, uniting financial and commercial data in a single platform and delivering insights around distribution and availability, insurance coverage hurdles and bureaucracy, and contracting ...
We are the data and application backbone for Life Sciences market access and commercialization. When a drug is commercialized, Life Sciences companies need to distribute product, support patients, and secure government and commercial contracts. IntegriChain uniquely delivers all the data, applications, and business process infrastructure that support those functions. More than 250 Life Sciences companies rely on our ICyte SaaS platform to power strategic decision-making for market access and commercialization. ICyte closes the data and systems chasm, uniting financial and commercial data in a single platform and delivering insights around distribution and availability, insurance coverage hurdles and bureaucracy, and contracting complexity to ensure patients have access to prescribed therapies. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. We are headquartered in Philadelphia, PA, with offices in Ambler, PA; Raleigh, NC; and Pune, India. Follow us on Twitter @integrichain.
-
Number of Employees:
250-1000
-
Annual Revenue:
$10-50 Million